Localization and reactivity of an immunodominant domain in the NS3 region of hepatitis C virus
- 1 March 1995
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 45 (3) , 273-281
- https://doi.org/10.1002/jmv.1890450306
Abstract
Analysis of the amino acid sequences of the non-structural region 3 (NS3) of the hepatitis C virus type 1 revealed four points with a high average hydrophilicity (Ah). Two of these potential anti-genie sites were expressed in E. coli as short fragments. The first fragment of 91 residues (NS3f3: residues 1359–1449) harbors the hexapeptide K-K-K-C-D-E with an Ah of 2.33; the second fragment is 73 residues long (NS3f4: residues 1460–1532) and encompasses the hep-tapeptide R-S-N-R-R-G-R with an Ah of 1.79. Both fragments were expressed with truncated hepatitis B core (tHBc) as a carrier protein. The fusion proteins were purified from the bacterial lysates by affinity chromatography on immobilized monoclonal antibodies against HBc, and evaluated as antigens in an enzyme immunoassay for the detection of HCV antibodies. In a specificity control panel, reactivity with NS3f3 was only found in proven HCV carriers, while reactivity with NS3f4 was weak in HCV carriers but accounted for some of the nonspecific serological reactions. In a group of 48 genotyped HCV-in-fected volunteer blood donors, antibodies against NS3f3 were detected in 90% (27/30) of HCV-type 1 infections and in all HCV-type 4 infections (5/5). However, in carriers infected with HCV-types 2, 3, or 5, the response rate was on average only 23% (3/13). With NS3f4 as antigen, weak antibody titers were found in only about half of the carriers, independent of the infectious genotype. In a cohort of hemodialysis patients, all infected with HCV-type 1b, NS3f3 antibodies were detected in 80% (16/20) of the carriers, while only one patient showed a weak NS3f4 reactivity. It is concluded that NS3f3 harbors an immunodominant domain of the NS3 region showing an apparently HCV-type-dependent serological response.Keywords
This publication has 24 references indexed in Scilit:
- Significance of NS3 and NS5 antigens in screening for HCV antibodyThe Lancet, 1994
- Evaluation of indeterminate c22‐3 reactivity in volunteer blood donorsTransfusion, 1994
- Hepatitis C Virus Blood Donor Screening Recombinant Immunoblot Assay Interpretation Re-ExaminedVox Sanguinis, 1993
- Hepatitis C Virus Confirmation in Blood Donor ScreeningVox Sanguinis, 1993
- A pattern of 5‐1‐1 and c100‐3 only on hepatitis C virus (HCV) recombinant immunoblot assay does not reflect HCV infection in blood donorsTransfusion, 1993
- Confirmation of Hepatitis C Virus Positive Blood Donors by Immunoblotting and Polymerase Chain ReactionVox Sanguinis, 1992
- Evaluation of anti-HCV capsid indeterminate serum samplesThe Lancet, 1992
- HCV genotypes in chronic hepatitis C and response to interferonThe Lancet, 1992
- Association of hepatitis C virus carrier state with the occurrence of hepatitis C virus core antibodiesJournal of Medical Virology, 1992
- Prediction of protein antigenic determinants from amino acid sequences.Proceedings of the National Academy of Sciences, 1981